Reading is good for you...
Reading about what's good for you is even better.
All about Ozempic
August 8, 2022
When to start birth control pills
August 10, 2022
Kyleena vs. Mirena IUDs
August 2, 2022
Get your Zyclara delivered at your door for FREE
Zyclara (Imiquimod) cream belongs to a group of medications called immune response modifiers. It works by stimulating the body's defenses to fight certain types of skin conditions.
VYLOMA 3.75% CRM 7.5G PUMP
We accept all insurance plans
**Actual price will depend on the insurance coverage in your province
Zyclara (Imiquimod) cream belongs to a group of medications called immune response modifiers. It works by stimulating the body's defenses to fight certain types of skin conditions. Zyclara (Imiquimod) cream is used to treat Actinic Keratosis (AK) on the face or balding scalp in adults. AK is a skin condition that could turn into Skin Cancer (symptoms include rough, red, scaly patches or lesions, or crusts) that is caused by chronic sun exposure.
Zyclara (Imiquimod) may be available under multiple brand names and/or in several different forms. Any specific brand name of Zyclara (Imiquimod) may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Zyclara (Imiquimod) may not be used for all of the conditions discussed here.
Your doctor may have suggested Zyclara (Imiquimod) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking Zyclara (Imiquimod), speak to your doctor. Do not stop taking Zyclara (Imiquimod) without consulting your doctor.
Do not give Zyclara (Imiquimod) to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take Zyclara (Imiquimod) if their doctor has not prescribed it.
Your medication is delivered directly to you at no added cost. We even offer same-day delivery in select locations.
Before applying the cream, wash your hands with soap and water, gently wash the treatment area with mild soap and water, and allow the skin to dry thoroughly. Apply Zyclara (Imiquimod) cream to the affected skin area once daily just before going to bed. Do not apply to areas larger than either the face or the balding scalp. Apply a thin layer of Zyclara (Imiquimod) onto the clean, dry AK lesion and rub gently into the skin until the cream is absorbed. Avoid contact with eyes, lips, and nostrils. If the cream gets in your eyes, rinse them with large amounts of water. Wash your hands after using the medication. Do not apply an occlusive dressing (one made of airtight material) over Zyclara (Imiquimod).
Leave the medication on the skin area for approximately 8 hours, and then remove it by washing the treated area with mild soap and water. Continue to use Zyclara (Imiquimod) for a total of 2 treatment cycles of 2 weeks, separated by a 2-week period with no treatment, or as directed by your doctor. A rest period from medication for several days may be taken depending on your discomfort and the severity of skin reactions, as directed by your doctor. Each treatment cycle should not last longer than 2 weeks even if a rest period is taken.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.
Zyclara (Imiquimod) is for external use only. Do not take it by mouth.
You may apply up to 2 packets or medication or 2 full actuations of the pump to the treatment area. If you are using the packets, use a new packet for each application. Throw away the remainder of an opened packet each time.
It is important to use Zyclara (Imiquimod) exactly as prescribed by your doctor. If you miss a dose, skip the missed dose and apply the cream at bedtime the next night. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Store Zyclara (Imiquimod) at room temperature, prevent it from freezing, and keep it out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.The side effects listed below are not experienced by everyone who takes Zyclara (Imiquimod). If you are concerned about side effects, discuss the risks and benefits of Zyclara (Imiquimod) with your doctor.
The following side effects have been reported by at least 1% of people taking Zyclara (Imiquimod). Many of these side effects can be managed, and some may go away on their own over time.Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not check with your doctor or seek medical attention.Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Zyclara (Imiquimod).
We manage your refills and get in touch with your doctors for prescription renewals so that you always have the medication you need.
Each gram of off-white to faintly yellow cream contains Zyclara (Imiquimod) 25 mg (2.5%). Nonmedicinal ingredients: isostearic acid, cetyl alcohol, stearyl alcohol, white petrolatum, polysorbate 60, sorbitan monostearate, glycerin, xanthan gum, purified water, benzyl alcohol, methylparaben, and propylparaben.
Each gram of off-white to faintly yellow cream contains Zyclara (Imiquimod) 37.5 mg (3.75%). Nonmedicinal ingredients: isostearic acid, cetyl alcohol, stearyl alcohol, white petrolatum, polysorbate 60, sorbitan monostearate, glycerin, xanthan gum, purified water, benzyl alcohol, methylparaben, and propylparaben.
Do not use Zyclara (Imiquimod) if you are allergic to Zyclara (Imiquimod) or any ingredients of the medication.
Our pharmacists are happy to answer your questions. Get in touch by text, live chat, phone or email. We're standing by 7 days a week.
There may be an interaction between Zyclara (Imiquimod) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Zyclara (Imiquimod). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Zyclara (Imiquimod).
Exposure to sunlight: You should avoid or minimize any exposure to sunlight (including sunlamps) and use protective clothing (such as long sleeves and a hat) during treatment with Zyclara (Imiquimod) cream due to an increased risk of Sunburn. If you get a sunburn, stop using the medication until you are fully recovered.
Immunosuppressed individuals: The safety and effectiveness of Zyclara (Imiquimod) cream has not been determined for people with medical conditions affecting the immune system (e.g., HIV/AIDS, Lupus, psoriasis) or people taking medications that reduce the effectiveness of the immune system. If you have any condition affecting the immune system, discuss with your doctor how Zyclara (Imiquimod) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Zyclara (Imiquimod), and whether any special monitoring is needed.
New actinic keratosis (AK) lesions: During treatment with Zyclara (Imiquimod) cream, new AK lesions may develop, but may clear with treatment. Even though initial AK lesions disappear with treatment, new lesions may develop in the future and will require further treatment. Keep in mind that AK is considered to be a chronic skin condition, and Zyclara (Imiquimod) cream is not a cure.
Skin colour changes: Some people using Zyclara (Imiquimod) cream notice that the area where the cream was applied has become lighter or darker. Sometimes, the change in skin colour is permanent.
Skin reactions: If you experience a severe skin reaction to this cream, wash the area with mild soap and water. Once the reaction has cleared, start using the cream again, unless your doctor has told you to stop using it.
Pregnancy: Zyclara (Imiquimod) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Zyclara (Imiquimod), contact your doctor immediately.
Breast-feeding: It is not known if Zyclara (Imiquimod) passes into breast milk. If you are a breast-feeding mother and are taking Zyclara (Imiquimod), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Zyclara (Imiquimod) have not been established for children under 18 years of age.
We sort your medication into clearly labeled, individual packs so you can be sure you're taking the right dose at the right time.
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
August 8, 2022
August 10, 2022
August 2, 2022